Export

EN
FR
Nifurtimox
Essential medicine status
Section:
6. Anti-infective medicines 6.5. Antiprotozoal medicines 6.5.5. Antitrypanosomal medicines 6.5.5.2. American trypanosomiasis
ATC codes: P01CC01
EMLc
Indication
Chagas disease ICD11 code: 1F53.Z
INN
Nifurtimox
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Oral > Solid > tablet: 30 mg (scored) ; 120 mg (scored)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1982 (TRS 685)
Changed in 1987 (TRS 770)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 950)
Changed in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Nifurtimox
DrugBank
Nifurtimox
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the deletion of nifurtimox 250 mg tablets from the EML and EMLc.